

Is Phenytoin XR still in shortage in 2026? Get the latest update on availability, pricing, and what to do if you can't find your medication.
If you take Phenytoin XR for seizure control, you've probably been following the supply issues that have affected this medication over the past few years. Between manufacturer changes, discontinued formulations, and supply chain disruptions, keeping your Phenytoin XR prescription filled has been harder than it should be.
In this update, we'll cover where things stand in 2026 — whether Phenytoin XR is still in shortage, what it costs, and what your options are if you're having trouble finding it.
As of early 2026, Phenytoin XR extended-release capsules are generally available but with intermittent disruptions depending on your area and the specific manufacturer your pharmacy stocks.
Here's what's been happening:
The ASHP (American Society of Health-System Pharmacists) and FDA continue to track phenytoin products on their shortage databases. While there isn't a formal nationwide shortage of the extended-release capsules, real-world availability can be hit-or-miss depending on where you live.
For more background, read why Phenytoin XR is so hard to find.
Several factors continue to affect Phenytoin XR availability in 2026:
As newer anticonvulsants like Levetiracetam and Lamotrigine have become first-line treatments, overall demand for Phenytoin has declined. This means fewer manufacturers see it as profitable to produce, which shrinks the supply base. When one manufacturer has a production issue, the remaining companies can't always absorb the extra demand.
The original brand, Dilantin, was developed by Pfizer and later transferred to Viatris Specialty LLC. These corporate transitions can create periods of confusion and supply gaps as distribution networks adjust.
Because Phenytoin has a narrow therapeutic index (effective blood level: 10-20 mcg/mL), the FDA requires strict bioequivalence standards for generic versions. This higher regulatory bar can slow new generics from entering the market and limit the number of approved manufacturers.
With the phenytoin oral suspension discontinued in some sizes and formulations, more patients are competing for the same pool of extended-release capsules.
Phenytoin XR is available as an affordable generic, which helps keep costs down for most patients:
Most Medicare and commercial insurance plans cover generic Phenytoin ER as a Tier 1 preferred generic, meaning your copay could be as low as $0 to $15. Brand-name Dilantin may require a higher copay or prior authorization.
For detailed savings tips, see our guide on how to save money on Phenytoin XR.
While no brand-new phenytoin formulations have launched, patients do have more options than ever when it comes to anticonvulsant therapy:
If you need to fill your prescription today, here's your action plan:
For more detailed strategies, read How to Find Phenytoin XR in Stock Near You.
Phenytoin XR remains an important medication for many epilepsy patients, and while it's generally available in 2026, spot shortages continue to cause frustration. The best thing you can do is stay proactive: refill early, use Medfinder to track availability, and keep an open dialogue with your neurologist about a backup plan.
If you're a healthcare provider looking for information on prescribing during the shortage, check out our provider shortage guide.
We'll continue to update this article as the supply situation evolves. Bookmark this page and check back for the latest information.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.